Yakir, M., Most, D., Hermel, J., Zimbric, M., Friedman, J., & Rho, J. (2023). Pediatric opsoclonus myoclonus ataxia syndrome in the setting of COVID-19 (P5-9.010). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1212/wnl.0000000000202711

Yakir, Maayan, Dana Most, Jonathan Hermel, Michael Zimbric, Jennifer Friedman, and Jong Rho. “Pediatric opsoclonus myoclonus ataxia syndrome in the setting of COVID-19 (P5-9.010).” Ovid Technologies (Wolters Kluwer Health), April 25, 2023. https://doi.org/10.1212/wnl.0000000000202711.

Yakir M, Most D, Hermel J, Zimbric M, Friedman J, Rho J. Pediatric opsoclonus myoclonus ataxia syndrome in the setting of COVID-19 (P5-9.010). Ovid Technologies (Wolters Kluwer Health); 2023 Apr.

Yakir, Maayan, et al. Pediatric opsoclonus myoclonus ataxia syndrome in the setting of COVID-19 (P5-9.010). Ovid Technologies (Wolters Kluwer Health), 25 Apr. 2023. Crossref, doi:10.1212/wnl.0000000000202711.

Yakir M, Most D, Hermel J, Zimbric M, Friedman J, Rho J. Pediatric opsoclonus myoclonus ataxia syndrome in the setting of COVID-19 (P5-9.010). Ovid Technologies (Wolters Kluwer Health); 2023 Apr.